VEGF165, Bcl-2, p53, COX-2 and HER-family expression in patients with stage IB-IIIA completely resected non-small cell lung cancer (NSCLC) and correlation with clinical outcome.

被引：0
|
作者：
Timotheadou, E
Murray, S
Linardou, H
Vrettou, AV
Skrickova, J
Kosmidis, P
Skarlos, DV
Pectasides, D
Fountzilas, G
机构：
[1] Papageorgiou Hosp, Dept Med Oncol, Thessaloniki, Greece
[2] Mol Biol & Genet Metropolitan Hosp, Athens, Greece
[3] Metropolitan Hosp, Dept Oncol, Athens, Greece
[4] Univ Hosp Brno, Brno, Czech Republic
[5] HYGEIA Hosp, Oncol Pathol Clin 2, Athens, Greece
[6] Errikos Dunant Hosp, B Oncol Dept, Athens, Greece
[7] Univ Athens, Attikon Hosp, Athens, Greece
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：681S / 681S
页数：1
相关论文
共 50 条
  • [31] Apoptosis occurs independently of bcl-2 and p53 over-expression in non-small cell lung carcinoma
    ONeill, AJ
    Staunton, MJ
    Gaffney, EF
    HISTOPATHOLOGY, 1996, 29 (01) : 45 - 50
  • [32] The predictive and prognostic value of the expression of p53 and bcl-2 in non-small cell lung carcinoma treated by radiotherapy
    Langendijk, JA
    Thunnissen, FBJM
    Lamers, RJS
    DeJong, JMA
    TenVelde, GPM
    Arends, JW
    Wouters, EFM
    2ND INTERNATIONAL CONGRESS ON LUNG CANCER, 1996, : 357 - 362
  • [33] Prognostic value of immunohistochemical expressions of p53, HER-2/neu, and bcl-2 in stage I non-small-cell lung cancer
    Han, H
    Landreneau, RJ
    Santucci, TS
    Tung, MY
    Macherey, RS
    Shackney, SE
    Sturgis, CD
    Raab, SS
    Silverman, JF
    HUMAN PATHOLOGY, 2002, 33 (01) : 105 - 110
  • [34] Clinical Impact of the Tumor Immune Microenvironment and Immunoscore in Completely Resected Stage IIIA(N2) Non-Small Cell Lung Cancer
    Feng, W.
    Fu, X.
    Cai, X.
    Zhang, Q.
    Zhang, J.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1872 - S1872
  • [35] p53 and HER2/neu expression in relation to chemotherapy response in patients with non-small cell lung cancer
    Fijolek, J.
    Wiatr, E.
    Rowinska-Zakrzewska, E.
    Giedronowicz, D.
    Langfort, R.
    Chabowski, M.
    Orlowski, T.
    Roszkowski, K.
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2006, 21 (02): : 81 - 87
  • [36] Prognostic value of immunohistochemical expression of p53, bax, Bcl-2 and Bcl-xL in resected non-small-cell lung cancers
    Groeger, AM
    Esposito, V
    De Luca, A
    Cassandro, R
    Tonini, G
    Ambrogi, V
    Baldi, F
    Goldfarb, R
    Mineo, TC
    Baldi, A
    Wolner, E
    HISTOPATHOLOGY, 2004, 44 (01) : 54 - 63
  • [37] A phase III clinical trial of adjuvant chemotherapy versus chemoimmunotherapy for stage IB-IIIA completely resected non-small cell lung cancer (NSCLC) patients nadim-adjuvant: New adjuvant trial of chemotherapy versus chemoimmunotherapy.
    Calvo, Virginia
    Domine, Manuel
    Sullivan, Ivana
    Gonzalez-Larriba, Jose-Luis
    Ortega, Ana Laura
    Bernabe, Reyes
    Sala, Maria Angeles
    Campos, Begona
    De Castro, Javier
    Martin-Martorell, Paloma
    Bosch-Barrera, Joaquim
    Mielgo, Xabier
    Vila, Laia
    Casal, Joaquin
    Ros, Silver
    Aguillo, Maite Martinez
    Padilla, Airam
    Sandiego, Sergio
    Machado, Jonathan Aires
    Provencio-Pulla, Mariano
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [38] Cyclooxygenase-2 expression in non-small cell lung cancer: Relation to expressions of p53, Bcl-2, Bax, tumor cell proliferation, and survival
    Sis, B
    Kargi, A
    Ulukus, C
    Oztop, I
    Akkoclu, A
    Sanli, A
    Onen, A
    LUNG CANCER, 2005, 49 : S295 - S295
  • [39] Prognostication by Cluster Analysis of COX-2, MMP-9 and P53 Expression and by Clinico-pathologic Correlation Analysis in Non-small Cell Lung Cancer
    Shin, Jong Wook
    Choi, Jae Ho
    Park, In Won
    Yoo, Jae Hyung
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2007, 63 (01) : 31 - 41
  • [40] Relevance of p53, bcl-2 and Rb expression on resistance to cisplatin-based chemotherapy in advanced non-small cell lung cancer
    Gregorc, V
    Ludovini, V
    Pistola, L
    Darwish, S
    Floriani, I
    Bellezza, G
    Sidoni, A
    Cavaliere, A
    Scheibel, M
    De Angelis, V
    Bucciarelli, E
    Tonato, M
    LUNG CANCER, 2003, 39 (01) : 41 - 48
12345